Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Phibro Animal Health Corp. (PAHC) PT Raised to $22 at Barclays
February 7, 2025 2:18 PM ESTBarclays analyst Balaji Prasad raised the price target on Phibro Animal Health Corp. (NASDAQ: PAHC) to $22.00 (from $20.00) while maintaining a Underweight rating.
The analyst comments "2QFY25 Rev / Adj. EPS beat cons by ~2%/~25%. Growth was led by AH (+11% excl. new MFA; +33%... More
